Clinical Trials for Priovant Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Priovant Therapeutics

Clinical Trials (3)

NCT06978725
A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)
PHASE2Recruiting
28 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT06431373
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
PHASE3Recruiting
300 participants
Started: Sep 11, 2024 · Completed: Feb 1, 2028
3 conditions1 sponsor40 locations
NCT05437263
A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis
PHASE3Active, not recruiting
241 participants
Started: Oct 31, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor109 locations